I doubt that because as the news sinks in, the reality of the results released this past week will also set in, ie that while interesting these are hardly data that indicate anything more that potential of this technology.
Not a big science guy but 2 of my partners are. The trial results in their eyes are pretty much in line with their expectations. They are of the notion that oncs is absoluteyl on the right path and that they should command a market capitalization much higher than 130 m. I think I'll listen to them.
Market Data 
Markets 
AI
